lenalidomide has been researched along with Ph 1 Chromosome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, B; Mu, Q; Ouyang, G; Sheng, L; Wang, Y; Xu, K; Zhang, Y; Zhu, H | 1 |
| Bauer, F; Dasanu, CA; Davis, LK; Reale, MA; Schwartz, RA; Silver, JS | 1 |
2 other study(ies) available for lenalidomide and Ph 1 Chromosome
| Article | Year |
|---|---|
Durable remission in a patient of mixed phenotype acute leukemia with Philadelphia chromosome-positive treated with nilotinib and lenalidomide: A case report.
Topics: Acute Disease; Antineoplastic Agents; Drug Therapy, Combination; Humans; Induction Chemotherapy; Lenalidomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Male; Middle Aged; Phenotype; Philadelphia Chromosome; Pyrimidines; Thalidomide | 2018 |
Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.
Topics: Aged; Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 5; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Lenalidomide; Myeloproliferative Disorders; Neoplasms; Philadelphia Chromosome; Polycythemia Vera; Splenomegaly; Thalidomide | 2011 |